SPS
PRAX icon

Susquehanna Portfolio Strategies’s Praxis Precision Medicines PRAX Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.49M Hold
23,251
– – 0.11% 231
2025
Q4 		$6.85M Hold
23,251
– – 0.11% 256
2025
Q3 		$1.23M Buy
23,251
+17,501
+304% +$849K 0.02% 629
2025
Q2 		$242K Buy
+5,750
New +$219K 0.01% 778

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Susquehanna Portfolio Strategies's PRAX Position: Q1 2026 in Review

Susquehanna Portfolio Strategies held its Praxis Precision Medicines (PRAX) position steady in Q1 2026 at 23,251 shares worth $7.49M. The position accounts for 0.11% of the portfolio, ranked #231.

Susquehanna Portfolio Strategies first reported a position in PRAX in Q2 2025 and has held it in 4 quarters since. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • Susquehanna Portfolio Strategies held 23,251 shares of Praxis Precision Medicines worth $7.49M as of Q1 2026.
  • Susquehanna Portfolio Strategies left its Praxis Precision Medicines share count unchanged in Q1 2026.
  • Praxis Precision Medicines made up 0.11% of Susquehanna Portfolio Strategies's portfolio in Q1 2026, its #231 holding.
  • Susquehanna Portfolio Strategies first reported a position in Praxis Precision Medicines in Q2 2025 and has held it in 4 quarters since.
  • 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.